Calls
1
u/LionLukeWay
Reddit r/pennystocks
Win Rate
100.0%
return
+160.2%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 27
$4.40
+160.2%
The author argues SLS is a long because the Phase 3 REGAL trial's slower-than-expected death rate implies the GPS arm is extending survival. They say the FDA's Jan 12, 2026 Bayesian Methodology guidance allows the IDMC to borrow Phase 2 data and potentially stop for superiority in February 2026 when the trial hits the 21-month median survival match from Phase 2. They also cite ~30% short interest and 19+ days to cover as a squeeze setup into a superiority headline, with the catalyst window in Q1 2026.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/LionLukeWay has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: SLS.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
